James B. Kahn

Dr. Kahn is a US Board-certified Infectious Diseases specialist with extensive expertise in policy modelling in health care, cost-effectiveness analysis, and evidence-based medicine. After practicing as an independent physician, Dr. Kahn joined Johnson and Johnson where he was responsible for the development of levofloxacin and ofloxacin at their Ortho-McNeil affiliate over nearly 20 years. He has authored/co-authored almost 140 peer-reviewed scientific papers and presentations in the area.

He remains an active member of national and international Infectious Diseases societies, including ASM,IDSA, ISID, and ESCMID. Dr. Kahn served two years as an EIS Officer at the US Center for Disease Control (CDC). He earned a B.A. from Harvard University and M.D. from Harvard Medical School. He the founder and principal of JBK Strategic Consultations, LLC, specialising in infectious disease expertise to the pharmaceutical industry.